Abstract
Background
The endocannabinoid system plays a crucial role in regulating mood, but the specific involvement of cannabinoid receptor type 2 (CB2R) in depression remains poorly understood. Similarly, the mechanisms by which electroacupuncture (EA) provides therapeutic benefits for depression are not clearly defined. This research aims to explore the function of CB2R in depression and examine if the therapeutic effects of EA are associated with the hippocampal CB2R system.Methods
Mice experiencing social defeat stress (SDS) were used to model depression and anxiety behaviors. We quantified hippocampal CB2R and N-arachidonoylethanolamide (AEA) levels. The efficacy of a CB2R agonist, JWH133, in mitigating SDS-induced behaviors was evaluated. Additionally, EA's impact on CB2R and AEA was assessed, along with the influence of CB2R antagonist AM630 on EA's antidepressant effects.Results
SDS led to depressive and anxiety-like behaviors, with corresponding decreases in hippocampal CB2R and AEA. Treatment with JWH133 ameliorated these behaviors. EA treatment resulted in increased CB2R and AEA levels, while AM630 blocked these antidepressant effects.Limitations
The study mainly focused on the SDS model, which may not entirely reflect other depression models. Besides, further investigation is needed to understand the precise mechanisms by which CB2R and AEA contribute to EA's effects.Conclusions
The study suggests hippocampal downregulation of CB2R and AEA contributes to depression. Upregulation of CB2R and AEA in response to EA suggests their involvement in EA's antidepressant effects. These findings provide insights into the role of the hippocampal CB2R system in depression and the potential mechanisms underlying EA's therapeutic effects.Citations & impact
Impact metrics
Article citations
The gut microbiome in patients with Cushing's disease affects depression- and anxiety-like behavior in mice.
Microbiome, 12(1):225, 01 Nov 2024
Cited by: 0 articles | PMID: 39482760 | PMCID: PMC11529176
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Activation of cannabinoid receptor type 2 attenuates surgery-induced cognitive impairment in mice through anti-inflammatory activity.
J Neuroinflammation, 14(1):138, 19 Jul 2017
Cited by: 38 articles | PMID: 28724382 | PMCID: PMC5518095
The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
Int Rev Neurobiol, 85:57-72, 01 Jan 2009
Cited by: 53 articles | PMID: 19607961
CB2R activation ameliorates late adolescent chronic alcohol exposure-induced anxiety-like behaviors during withdrawal by preventing morphological changes and suppressing NLRP3 inflammasome activation in prefrontal cortex microglia in mice.
Brain Behav Immun, 110:60-79, 06 Feb 2023
Cited by: 18 articles | PMID: 36754245
Pharmacological potential of JWH133, a cannabinoid type 2 receptor agonist in neurodegenerative, neurodevelopmental and neuropsychiatric diseases.
Eur J Pharmacol, 909:174398, 29 Jul 2021
Cited by: 2 articles | PMID: 34332924
Review